Versatile roles of Annexin A4 in ccRCC: impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment

Maximilian Wess, Manuel Rogg, Constance Gueib-Picard, Annika Merz, Anna L. Koessinger, Tobias Feilen, Grigor Andreev, Martin Werner, Ian J. Frew, Markus Grabbert, Oliver Schilling, Christoph SchellbioRxiv 2024 · DOI

TL;DR

This study reveals Annexin A4 (ANXA4) as a key player in clear cell renal cell carcinoma (ccRCC), demonstrating its crucial roles in plasma membrane repair, regulating gene expression, and shaping the tumor microenvironment. By integrating multi-omics and advanced imaging, the research uncovers ANXA4's potential as a diagnostic and therapeutic target in this aggressive cancer.

What Problem Does This Paper Address?

Clear cell renal cell carcinoma (ccRCC) is a deadly cancer, especially when it metastasizes. Cancer cells grow invasively, which involves significant mechanical stress and damage to their plasma membranes. While the importance of plasma membrane repair for cancer cell survival and invasion is recognized, the specific molecular mechanisms involved in ccRCC are not fully understood. The authors investigate the annexin protein family, known for their membrane-associated functions, to identify novel players in ccRCC pathogenesis. Specifically, they aim to understand the role of ANXA4, a protein found to be selectively expressed in ccRCC cells, in processes like membrane repair, gene regulation, and the tumor's surrounding environment.

Methods

The researchers employed a multi-pronged approach:

  • Proteomics and Transcriptomics: They analyzed global annexin protein expression in ccRCC tissues and cell lines using proteomic datasets and RNA sequencing.
  • Single-Cell RNA Sequencing (scRNA-Seq): To pinpoint ANXA4's cellular specificity, they used scRNA-Seq data to deconvolute expression patterns within tumor samples.
  • Immunohistochemistry (IHC): This technique was used to visualize ANXA4 localization within tumor tissues, providing spatial context.
  • Genetic Manipulation: They used knockdown (shRNA), knockout (CRISPR/Cas9), and overexpression techniques in ccRCC cell lines to study ANXA4's functional impact.
  • In Vitro Assays: Standard assays were used to assess cell proliferation (BrdU, Incucyte), migration, and invasion (Transwell assays, gap closure).
  • Plasma Membrane Repair Assays: Specialized assays were developed to measure the cell's ability to repair membrane damage under stress conditions (digitonin, hypoosmolarity).
  • Machine Learning-Based Histopathological Segmentation: Advanced computational methods were used to analyze tissue composition, identifying cellular neighborhoods and quantifying immune cell infiltration and extracellular matrix deposition.
  • Transcription Factor Enrichment Analysis: Techniques like ChEA3 were used to identify key regulatory proteins influencing gene expression changes.

Datasets

  • Proteomic Datasets: Multiple published proteomic datasets of ccRCC tumor tissue were analyzed.
  • Transcriptomic Datasets: Publicly available transcriptomic data (e.g., CPTAC, TCGA) were utilized.
  • scRNA-Seq Data: Data from a previously published scRNA-Seq cohort of ccRCC was used for cellular deconvolution.
  • Cancer Cell Line Encyclopedia (CCLE): Used for analyzing gene expression in kidney cancer cell lines and their VHL mutation status.
  • CPTAC-CCRCC Dataset: This dataset, including HE-stained FFPE tissue samples, was used for detailed histopathological analysis.

Key Insights and Ideas

  • ANXA4 as a ccRCC-Specific Marker: The study strongly suggests ANXA4 is highly specific to ccRCC tumor cells, distinguishing them from normal tissue and other cell types within the tumor microenvironment.
  • Dynamic Subcellular Localization: ANXA4 isn't static; its location shifts between the cytoplasm, plasma membrane, and nuclear membrane depending on cellular stress and density. This dynamic nature hints at diverse functional roles.
  • Membrane Repair is Crucial: ANXA4's recruitment to the plasma membrane under stress conditions directly links it to acute membrane repair. Reduced ANXA4 impairs this repair, suggesting a vulnerability in cancer cells.
  • TME Modulation: ANXA4 levels significantly correlate with the composition of the tumor microenvironment, influencing immune cell infiltration and extracellular matrix deposition. This suggests ANXA4 plays a role in the broader tumor ecosystem.
  • ELF3 as a Key Regulator: The transcription factor ELF3 emerges as a critical downstream effector of ANXA4, influencing invasive phenotypes and potentially acting as a tumor suppressor.

Key Results

  • ANXA4 Upregulation: ANXA4 is significantly upregulated in ccRCC tumor cells compared to normal tissue and shows higher expression in ccRCC cell lines, particularly those with VHL loss.
  • Survival Correlation: Lower ANXA4 expression in patients is associated with decreased overall survival, higher tumor grades, and increased lymph node involvement.
  • Membrane Repair Impairment: Knockdown of ANXA4 leads to impaired plasma membrane repair capacity in ccRCC cells.
  • Invasive Phenotype Modulation: While ANXA4 loss didn't affect general migration, it impaired invasion through Matrigel, and ELF3 overexpression mimicked this effect.
  • TME Alterations: ANXA4-low tumors exhibit increased lymphocyte infiltration and extracellular matrix deposition (collagens, laminins).
  • Transcriptomic Signatures: ANXA4 knockout cells show altered gene expression related to extracellular matrix, immune signaling, and epithelial-mesenchymal transition (EMT).
  • ELF3 Upregulation: ANXA4 knockout leads to increased ELF3 expression, and ELF3 overexpression suppresses invasive migration.

Limitations and Future Work

  • Proliferation Not Affected: The study found no significant impact of ANXA4 on cellular proliferation in ccRCC cell lines, which contrasts with findings in other cancer types. The authors suggest this might be due to the inherent low proliferative behavior of ccRCC or differences in cell lines used.
  • Context-Dependent Roles: The authors acknowledge that annexin proteins, including ANXA4, can have context-dependent roles, suggesting further investigation into these nuances.
  • Mechanistic Dissection: While ANXA4's roles are uncovered, future studies are needed to fully dissect the complex interplay of individual annexin proteins in ccRCC and their precise mechanisms of action.
  • Therapeutic Exploitation: The findings suggest ANXA4 could be a target for diagnostic or therapeutic interventions, which warrants further research and validation.
  • VHL Dependency: The study implies a pVHL-dependent regulation of ANXA4, suggesting a link to the hypoxic signaling pathway common in ccRCC. Further exploration of this pathway is warranted.

Summary updated

Abstract

Abstract Clear cell renal cell carcinoma (ccRCC) is the most prevalent type of renal malignant disease and is characterized by dismal prognosis in the metastasized setting. Invasive growth of cancer cells relates to high levels of compressive forces translating to relevant damage of the plasma membrane. However, functional implications of protein machineries required for plasma membrane repair in ccRCC are not yet completely elucidated. Given the membrane-associated localization of the large family of annexin proteins, we aimed for a global annotation of annexin proteins, which led to the identification of ANXA4 selectively expressed in cancer cells of ccRCC. Interestingly, ANXA4 showed context-dependent distinct localization patterns including the plasma membrane as well as the nuclear compartment/nuclear membrane. We investigated the functional role of ANXA4 in ccRCC employing genetic titration studies (knockdown, CRISPR/Cas9 knockout and overexpression) and identified impaired acute plasma membrane repair as well as invasive capability in conditions of reduced ANXA4 expression. Utilizing computational segmentation of the tumor microenvironment (TME) of ccRCC samples revealed that ANXA4 low tumors exhibited a distinct TME composition compared to ANXA4 high cases. ANXA4 low tumors showed higher levels of tumor infiltrating lymphocytes accompanied by increased deposition of acellular extracellular matrix. Further transcriptomic analysis demonstrated major alterations in transcriptional signatures related to epithelial-mesenchymal transition (EMT) and immune signaling. Transcription factor enrichment analysis and further functional validation identified ELF3 as one central regulator of invasive properties. Our integrative approach including molecular analyses with advanced histopathological segmentation uncovered novel roles for ANXA4 in modulating acute membrane repair, transcriptional regulation, and shaping cellular composition of the ccRCC tumor microenvironment.
BibTeX
@misc{wess2024versatile,
  author = {Maximilian Wess and Manuel Rogg and Constance Gueib-Picard and Annika Merz and Anna L. Koessinger and Tobias Feilen and Grigor Andreev and Martin Werner and Ian J. Frew and Markus Grabbert and Oliver Schilling and Christoph Schell},
  title = {{Versatile roles of Annexin A4 in ccRCC: impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment}},
  year = {2024},
  doi = {10.1101/2024.05.31.596161},
  howpublished = {bioRxiv},
}
Figure